Results for tag: "Muscarinic Agonist"

The Muscarinic Agonist market is a subset of the Central Nervous System Drugs market. Muscarinic agonists are drugs that activate muscarinic receptors, which are found in the central nervous system and are involved in a variety of physiological processes. These drugs are used to treat a variety of conditions, including Alzheimer's disease, Parkinson's disease, and urinary incontinence. They are also used to treat certain types of glaucoma and to reduce the side effects of antipsychotic medications. The Muscarinic Agonist market is highly competitive, with a number of large pharmaceutical companies competing for market share. Some of the major players in the market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Sanofi, and Teva Pharmaceuticals. Show Less Read more